Clinical Trial Update: Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX-CRC Trial. [Phase 2]

View source ↗

Summary

Phase II trial AVETUX-CRC studied avelumab plus cetuximab with FOLFOX in previously untreated metastatic colorectal cancer; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avelumab (avelumab)
• Cetuximab (cetuximab)
• FOLFOX

Snippet

Sponsor: AIO-Studien-gGmbH | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED